Treating pain has long been a challenge. Over-the-counter treatments often don’t do enough, while opioids block pain signals but can be extremely addictive. Vertex broke those barriers with Journavx, ...

If you're holding shares of Vertex Pharmaceuticals or thinking about adding some to your portfolio, you're not alone in wondering what the right move is. The stock's recent momentum may have caught ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Vertex Pharmaceuticals’ CRISPR-based therapy made history as ...

KING OF PRUSSIA, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Stoke’s new CEO has a long ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

CAGAYAN DE ORO CITY — The Social Security System (SSS) has stepped up efforts to collect unpaid social security premium contributions, with at least 200 individuals recently served with demand letters ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Vertex isn't your run-of-the-mill biotech stock. Warren Buffett famously said that he and his investing managers "attempt to be fearful when others are greedy, and to be greedy only when others are ...

CEBU, Philippines — The Social Security System (SSS) announced that starting October 2, 2025 its Calamity Loan Program is now available for members affected by the 6.9-magnitude earthquake that struck ...

The 2025 edition of Time’s annual “best inventions” list saw the magazine expand the docket from 200 to 300 innovations—more than 10% of which comprise medical devices, pharmaceuticals and other novel ...